- 1.
Jagasia MH, Greinix HT, Arora M et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015; 21: 389–401.e1. [PubMed][CrossRef]
- 2.
Zeiser R, Blazar BR. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets. N Engl J Med 2017; 377: 2565–79. [PubMed][CrossRef]
- 3.
Lee SJ, Klein J, Haagenson M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576–83. [PubMed][CrossRef]
- 4.
Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459–64. [PubMed][CrossRef]
- 5.
Vo DD, Myhre AE, Abrahamsen IW et al. Allogen stamcelletransplantasjon hos voksne 2015 – 2021. Tidsskr Nor Legeforen 2023; 143. doi: 10.4045/tidsskr.22.0521. [CrossRef]
- 6.
Jacobsohn DA, Kurland BF, Pidala J et al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood 2012; 120: 2545–52, quiz 2774. [PubMed][CrossRef]
- 7.
Carreno-Galeano JT, Dohlman TH, Kim S et al. A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management. Ocul Immunol Inflamm 2021; 29: 1190–9. [PubMed][CrossRef]
- 8.
Dean D, Sroussi H. Oral Chronic Graft-Versus-Host Disease. Front Oral Health 2022; 3: 903154. [PubMed][CrossRef]
- 9.
Hamilton BK, Goje O, Savani BN et al. Clinical management of genital chronic GvHD. Bone Marrow Transplant 2017; 52: 803–10. [PubMed][CrossRef]
- 10.
Hildebrandt GC, Fazekas T, Lawitschka A et al. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011; 46: 1283–95. [PubMed][CrossRef]
- 11.
Strasser SI, Shulman HM, Flowers ME et al. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000; 32: 1265–71. [PubMed][CrossRef]
- 12.
Chen BJ. Chronic GVHD of the CNS. Blood 2022; 139: 1271–2. [PubMed][CrossRef]
- 13.
Leuven UZ. eGHVD. https://www.uzleuven.be/egvhd Lest 19.12.2022.
- 14.
Schoemans HM, Goris K, Van Durm R et al. The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial. Haematologica 2018; 103: 1698–707. [PubMed][CrossRef]
- 15.
Vogelsang GB, Pavletic SZ. Chronic graft versus host disease: interdisciplinary management. Cambridge: Cambridge University Press; 2009.
- 16.
Carreras E, Dufour C, Mohty M et al. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Cham: Springer International Publishing, 2019.
- 17.
Zeiser R, Polverelli N, Ram R et al. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. N Engl J Med 2021; 385: 228–38. [PubMed][CrossRef]
- 18.
Jagasia M, Scheid C, Socié G et al. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. Blood Adv 2019; 3: 2218–29. [PubMed][CrossRef]
- 19.
Vigorito AC, Campregher PV, Storer BE et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009; 114: 702–8. [PubMed][CrossRef]
- 20.
Styczynski J, Reusser P, Einsele H et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 2009; 43: 757–70. [PubMed][CrossRef]
- 21.
Maertens J, Cesaro S, Maschmeyer G et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 2016; 71: 2397–404. [PubMed][CrossRef]
- 22.
Tomblyn M, Chiller T, Einsele H et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–238. [PubMed][CrossRef]
- 23.
Maertens JA, Girmenia C, Brüggemann RJ et al. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother 2018; 73: 3221–30. [PubMed][CrossRef]
- 24.
Furuseth E. Vaksinasjon ved immunsvikt. https://www.fhi.no/nettpub/vaksinasjonsveilederen-for-helsepersonell/vaksinasjon-ved-sykdom/vaksinasjon-ved-medfodt-immunsvikt/ Lest 19.12.2022.
- 25.
Rubin LG, Levin MJ, Ljungman P et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58: e44–100. [PubMed][CrossRef]
()